Literature DB >> 19193840

Truncated human cytidylate-phosphate-deoxyguanylate-binding protein for improved nucleic acid amplification technique-based detection of bacterial species in human samples.

Svea Sachse1, Eberhard Straube, Marc Lehmann, Michael Bauer, Stefan Russwurm, Karl-Hermann Schmidt.   

Abstract

A trunk of human cytidylate-phosphate-deoxyguanylate-binding protein/CXXC finger protein 1 (CFP1), immobilized onto an aminohexyl-Sepharose column, can be used as a preanalytical tool for the selective enrichment of bacterial DNA from mixed solutions with high amounts of human background DNA for nucleic acid amplification technique-based detection of pathogens. The transcriptional activator protein exhibits a high affinity for nonmethylated CpG dinucleotide motifs, which are differentially distributed in prokaryotic and higher eukaryotic genomes. The feasibility of the affinity chromatography (AC) step was tested with DNA from severely septic patients. AC using 16S rRNA gene primers substantially increased PCR sensitivity. Approximately 90% of eukaryotic DNA was removed, which significantly increased the signal-to-noise ratio. Threshold cycle values revealed that sensitivity was elevated at least 10-fold. The change in the ratio of bacterial DNA to human DNA increased from 26% to 74% the likelihood of culture-independent PCR-based identification of bacterial presence. Compared to the results seen with blood culture (which is the clinical gold standard for systemic infections, exhibiting 28% positives), the combination of AC and PCR achieves a significant increase in sensitivity and contributes to shortening the time to results for the initiation of guided antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193840      PMCID: PMC2668332          DOI: 10.1128/JCM.02242-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

Review 1.  16S rRNA gene sequencing for bacterial pathogen identification in the clinical laboratory.

Authors:  J B Patel
Journal:  Mol Diagn       Date:  2001-12

2.  Identification and characterization of the DNA binding domain of CpG-binding protein.

Authors:  J H Lee; K S Voo; D G Skalnik
Journal:  J Biol Chem       Date:  2001-09-25       Impact factor: 5.157

3.  Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients.

Authors:  Eugen Domann; George Hong; Can Imirzalioglu; Simon Turschner; Johannes Kühle; Corinna Watzel; Torsten Hain; Hamid Hossain; Trinad Chakraborty
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 4.  Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.

Authors:  Pierre-Yves Bochud; Marc Bonten; Oscar Marchetti; Thierry Calandra
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

Review 5.  New developments in the diagnosis of bloodstream infections.

Authors:  Remco P H Peters; Michiel A van Agtmael; Sven A Danner; Paul H M Savelkoul; Christina M J E Vandenbroucke-Grauls
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

6.  Overrepresentation of immunostimulatory CpG motifs in Burkholderia genomes.

Authors:  Tom Coenye; Peter Vandamme
Journal:  J Cyst Fibros       Date:  2005-09       Impact factor: 5.482

7.  Rapid diagnosis of bacterial sepsis with PCR amplification and microarray hybridization in 16S rRNA gene.

Authors:  Shiqiang Shang; Guoxian Chen; Yidong Wu; Lizhong DU; Zhengyan Zhao
Journal:  Pediatr Res       Date:  2005-06-27       Impact factor: 3.756

8.  Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

Authors:  Jose Garnacho-Montero; Jose Luis Garcia-Garmendia; Ana Barrero-Almodovar; Francisco J Jimenez-Jimenez; Carmen Perez-Paredes; Carlos Ortiz-Leyba
Journal:  Crit Care Med       Date:  2003-12       Impact factor: 7.598

9.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

Authors:  Jordi Vallés; Jordi Rello; Ana Ochagavía; José Garnacho; Miguel Angel Alcalá
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

10.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

View more
  14 in total

1.  Non-culture-based methods to diagnose bloodstream infection: Does it work?

Authors:  Miha Skvarc; David Stubljar; Petra Rogina; Achim J Kaasch
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-06-05

2.  Improved sensitivity for molecular detection of bacterial and Candida infections in blood.

Authors:  Andrea Bacconi; Gregory S Richmond; Michelle A Baroldi; Thomas G Laffler; Lawrence B Blyn; Heather E Carolan; Mark R Frinder; Donna M Toleno; David Metzgar; Jose R Gutierrez; Christian Massire; Megan Rounds; Natalie J Kennel; Richard E Rothman; Stephen Peterson; Karen C Carroll; Teresa Wakefield; David J Ecker; Rangarajan Sampath
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

Review 3.  Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view.

Authors:  Mathias W Pletz; Nele Wellinghausen; Tobias Welte
Journal:  Intensive Care Med       Date:  2011-05-15       Impact factor: 17.440

4.  Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients.

Authors:  Jan Springer; Juergen Loeffler; Werner Heinz; Hannes Schlossnagel; Marc Lehmann; Oliver Morton; Thomas R Rogers; Corinna Schmitt; Matthias Frosch; Hermann Einsele; Oliver Kurzai
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 6.  Advances in Candida detection platforms for clinical and point-of-care applications.

Authors:  Mohammadali Safavieh; Chad Coarsey; Nwadiuto Esiobu; Adnan Memic; Jatin Mahesh Vyas; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Biotechnol       Date:  2016-04-19       Impact factor: 8.429

7.  Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.

Authors:  Tucker Maxson; Douglas A Mitchell
Journal:  Tetrahedron       Date:  2015-10-09       Impact factor: 2.457

8.  Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study.

Authors:  Frank Bloos; Svea Sachse; Andreas Kortgen; Mathias W Pletz; Marc Lehmann; Eberhard Straube; Niels C Riedemann; Konrad Reinhart; Michael Bauer
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

Review 9.  Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?

Authors:  Arash Afshari; Jacques Schrenzel; Margareta Ieven; Stephan Harbarth
Journal:  Crit Care       Date:  2012-05-29       Impact factor: 9.097

10.  Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Authors:  Mario Cruciani; Carlo Mengoli; Rosemary Barnes; J Peter Donnelly; Juergen Loeffler; Brian L Jones; Lena Klingspor; Johan Maertens; Charles O Morton; Lewis P White
Journal:  Cochrane Database Syst Rev       Date:  2019-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.